These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6593004)
1. [A comparative study of 4'-epi-doxorubicin and doxorubicin cardiotoxicities]. Suzuki T; Yamamoto H; Iwasaki T; Okamoto S; Iizuka T; Kanda H; Murata K Gan To Kagaku Ryoho; 1984 Oct; 11(10):2170-6. PubMed ID: 6593004 [TBL] [Abstract][Full Text] [Related]
2. Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects. Neri B; Cini-Neri G; Bandinelli M; Pacini P; Bartalucci S; Ciapini A Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):217-21. PubMed ID: 2737789 [TBL] [Abstract][Full Text] [Related]
3. Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats. Broggini M; Colombo T; Martini A; Donelli MG Cancer Treat Rep; 1980; 64(8-9):897-904. PubMed ID: 6934850 [TBL] [Abstract][Full Text] [Related]
4. Comparative studies of doxorubicin and 4'-epidoxorubicin effects on cardiovascular system in rabbits. Fronczak A; Drzewoski J; Polakowski P Pol J Pharmacol Pharm; 1989; 41(6):597-609. PubMed ID: 2485907 [TBL] [Abstract][Full Text] [Related]
5. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat. Hirano S; Wakazono K; Agata N; Iguchi H; Tone H Drugs Exp Clin Res; 1994; 20(4):153-60. PubMed ID: 7813387 [TBL] [Abstract][Full Text] [Related]
6. Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens. De Leonardis V; De Scalzi M; Neri B; Bartalucci S; Cinelli P Int J Clin Pharmacol Res; 1987; 7(4):307-11. PubMed ID: 3474215 [TBL] [Abstract][Full Text] [Related]
7. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. Working PK; Newman MS; Sullivan T; Yarrington J J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696 [TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice. Chan P Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179 [TBL] [Abstract][Full Text] [Related]
9. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin. Tham P; Dougherty W; Iatropoulos MJ; Gordon G; James VC; Hall C; Noble JF Am J Pathol; 1987 Jul; 128(1):121-30. PubMed ID: 3605309 [TBL] [Abstract][Full Text] [Related]
10. Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study. Camaggi CM; Comparsi R; Strocchi E; Testoni F; Angelelli B; Pannuti F Cancer Chemother Pharmacol; 1988; 21(3):221-8. PubMed ID: 3162849 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678 [TBL] [Abstract][Full Text] [Related]
12. Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients. Camaggi CM; Strocchi E; Martoni A; Angelelli B; Comparsi R; Pannuti F Drugs Exp Clin Res; 1985; 11(4):285-94. PubMed ID: 3869807 [TBL] [Abstract][Full Text] [Related]
13. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
15. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study. Koutinos G; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656 [TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration. Saad SY; Najjar TA; Alashari M J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2000 Mar; 470():1-330. PubMed ID: 12579203 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287 [TBL] [Abstract][Full Text] [Related]